ID: ALA5271822

Max Phase: Preclinical

Molecular Formula: C16H10O8

Molecular Weight: 330.25

Associated Items:

Representations

Canonical SMILES:  COC(=O)c1c(O)ccc2oc3cc(C(=O)O)cc(O)c3c(=O)c12

Standard InChI:  InChI=1S/C16H10O8/c1-23-16(22)12-7(17)2-3-9-13(12)14(19)11-8(18)4-6(15(20)21)5-10(11)24-9/h2-5,17-18H,1H3,(H,20,21)

Standard InChI Key:  SEEWMSOVGSUOJV-UHFFFAOYSA-N

Associated Targets(non-human)

Alpha-glucosidase 187 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 330.25Molecular Weight (Monoisotopic): 330.0376AlogP: 1.84#Rotatable Bonds: 2
Polar Surface Area: 134.27Molecular Species: ACIDHBA: 7HBD: 3
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.33CX Basic pKa: CX LogP: 3.31CX LogD: -0.15
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.48Np Likeness Score: 1.13

References

1. Santos CMM, Freitas M, Fernandes E..  (2018)  A comprehensive review on xanthone derivatives as α-glucosidase inhibitors.,  157  [PMID:30282319] [10.1016/j.ejmech.2018.07.073]

Source